IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis ...Middle East

SHANGHAI, NANJING, China and SAN JOSE, Calif., July 23, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, announced that the...

Hence then, the article about iaso bio receives u s fda approval of investigational new drug application for equecabtagene autoleucel for multiple sclerosis was published today ( Wednesday 24/07/2024 - 05:01 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis )

Also on site :

• Trump endorses Steven Hilton in California governor's race
• 10 Years Ago Today, Country Music Legend Died on His 79th Birthday After Eerily Predicting He Would
• This 1954 Film Ranked as Alfred Hitchcock's No. 1 'Masterpiece'